Mallik Greene

867 total citations
49 papers, 563 citations indexed

About

Mallik Greene is a scholar working on Psychiatry and Mental health, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mallik Greene has authored 49 papers receiving a total of 563 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Psychiatry and Mental health, 20 papers in Oncology and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mallik Greene's work include Colorectal Cancer Screening and Detection (20 papers), Schizophrenia research and treatment (19 papers) and Bipolar Disorder and Treatment (18 papers). Mallik Greene is often cited by papers focused on Colorectal Cancer Screening and Detection (20 papers), Schizophrenia research and treatment (19 papers) and Bipolar Disorder and Treatment (18 papers). Mallik Greene collaborates with scholars based in United States, Spain and Denmark. Mallik Greene's co-authors include Maëlys Touya, Michael S. Broder, Eunice Chang, Ann Hartry, Tingjian Yan, Eric Q. Wu, Annie Guérin, Martin Cloutier, O Clark and Chakkarin Burudpakdee and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Mallik Greene

38 papers receiving 555 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mallik Greene United States 11 455 92 70 66 64 49 563
Maëlys Touya United States 11 368 0.8× 86 0.9× 110 1.6× 81 1.2× 46 0.7× 29 593
Ola Granström Sweden 8 474 1.0× 190 2.1× 56 0.8× 132 2.0× 84 1.3× 13 722
Frank D. Gianfrancesco United States 13 524 1.2× 74 0.8× 54 0.8× 31 0.5× 31 0.5× 31 643
Dana Enkusson Sweden 5 581 1.3× 177 1.9× 75 1.1× 91 1.4× 172 2.7× 9 691
Maila Majak Sweden 6 581 1.3× 176 1.9× 77 1.1× 91 1.4× 172 2.7× 8 734
Danielle Adams Australia 11 271 0.6× 80 0.9× 63 0.9× 38 0.6× 20 0.3× 27 428
Rodrigo Muñoz United States 8 157 0.3× 96 1.0× 33 0.5× 37 0.6× 58 0.9× 16 371
B. Lachaux France 9 476 1.0× 182 2.0× 58 0.8× 62 0.9× 227 3.5× 30 601
Fernando Cañas Spain 15 317 0.7× 127 1.4× 32 0.5× 39 0.6× 71 1.1× 29 478
Jacqueline Zummo United States 13 566 1.2× 139 1.5× 82 1.2× 57 0.9× 146 2.3× 28 764

Countries citing papers authored by Mallik Greene

Since Specialization
Citations

This map shows the geographic impact of Mallik Greene's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mallik Greene with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mallik Greene more than expected).

Fields of papers citing papers by Mallik Greene

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mallik Greene. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mallik Greene. The network helps show where Mallik Greene may publish in the future.

Co-authorship network of co-authors of Mallik Greene

This figure shows the co-authorship network connecting the top 25 collaborators of Mallik Greene. A scholar is included among the top collaborators of Mallik Greene based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mallik Greene. Mallik Greene is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Greene, Mallik, et al.. (2025). Closing the loop in colorectal cancer screening: real-world adherence to follow-up colonoscopy after positive mt-sDNA vs FIT/FOBT, stratified by payer type. Current Medical Research and Opinion. 41(9). 1629–1639. 1 indexed citations
2.
Greene, Mallik, Quang A. Le, A. Burak Ozbay, Jordan J. Karlitz, & A. Mark Fendrick. (2025). Completing the colorectal cancer screening process: impact of eliminating cost-sharing for follow-up colonoscopy. Current Medical Research and Opinion. 41(9). 1697–1703.
3.
Greene, Mallik, et al.. (2025). Adherence to Multitarget Stool DNA Testing in Individuals Aged 45–49 Years With Average Risk for Colorectal Cancer. Clinical and Translational Gastroenterology. 16(9). e00878–e00878.
4.
Fendrick, A. Mark, Mallik Greene, A. Burak Ozbay, et al.. (2025). Patient and physician preferences among colorectal cancer screening tests: updated predictions from a discrete choice experiment. Current Medical Research and Opinion. 41(10). 1951–1963.
5.
Greene, Mallik, et al.. (2025). Adherence to mt-sDNA testing for colorectal cancer screening among new users in a US Black population. Current Medical Research and Opinion. 41(3). 513–520. 1 indexed citations
6.
Greene, Mallik, et al.. (2025). Impact of Digital Navigation on Screening Adherence With the Multi-Target Stool DNA Test. Journal of health economics and outcomes research. 12(1). 191–200.
7.
8.
Greene, Mallik, Quang A. Le, A. Burak Ozbay, et al.. (2025). Trends in utilization of colorectal cancer screening modalities among patients with average risk in the United States from 2017 to 2023.. Journal of Clinical Oncology. 43(4_suppl). 98–98. 1 indexed citations
9.
Chamberlain, Alanna M., et al.. (2025). Follow-up Colorectal Cancer Screening After Negative-Result and Positive-Result Multitarget Stool DNA Tests: A Population-Based Study in Southeast Minnesota. Mayo Clinic Proceedings Innovations Quality & Outcomes. 9(2). 100599–100599.
10.
Karlitz, Jordan J., et al.. (2025). Adherence to multi-target stool DNA colorectal cancer screening and clinical follow-up in the Hartford HealthCare system. International Journal of Colorectal Disease. 40(1). 200–200.
11.
12.
13.
Tang, Yan, et al.. (2020). Impact of Atypical Antipsychotics as Adjunctive Therapy on Psychiatric Cost and Utilization in Patients with Major Depressive Disorder. SHILAP Revista de lepidopterología. 1 indexed citations
14.
Tandon, Rajiv, William R. Lenderking, Catherine Weiss, et al.. (2020). The impact on functioning of second-generation antipsychotic medication side effects for patients with schizophrenia: a worldwide, cross-sectional, web-based survey. Annals of General Psychiatry. 19(1). 42–42. 48 indexed citations
15.
Yan, Tingjian, Mallik Greene, Eunice Chang, et al.. (2020). Health Care Cost in Patients With Schizophrenia Treated With Brexpiprazole Versus Other Oral Atypical Antipsychotic Therapy. Clinical Therapeutics. 42(1). 77–93. 4 indexed citations
16.
Greene, Mallik, et al.. (2019). <p>Real-World Economic Outcomes of Brexpiprazole and Extended-Release Quetiapine Adjunctive Use in Major Depressive Disorder</p>. ClinicoEconomics and Outcomes Research. Volume 11. 741–755. 4 indexed citations
17.
Broder, Michael S., Mallik Greene, Tingjian Yan, et al.. (2019). Medication Adherence, Health Care Utilization, and Costs in Patients With Major Depressive Disorder Initiating Adjunctive Atypical Antipsychotic Treatment. Clinical Therapeutics. 41(2). 221–232. 6 indexed citations
18.
Greene, Mallik, et al.. (2018). Systematic literature review on patterns of pharmacological treatment and adherence among patients with bipolar disorder type I in the USA. Neuropsychiatric Disease and Treatment. Volume 14. 1545–1559. 27 indexed citations
19.
Greene, Mallik, Tingjian Yan, Eunice Chang, et al.. (2017). Medication adherence and discontinuation of long-acting injectable versus oral antipsychotics in patients with schizophrenia or bipolar disorder. Journal of Medical Economics. 21(2). 127–134. 139 indexed citations
20.
Cloutier, Martin, Mallik Greene, Annie Guérin, Maëlys Touya, & Eric Q. Wu. (2017). The economic burden of bipolar I disorder in the United States in 2015. Journal of Affective Disorders. 226. 45–51. 123 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maëlys Touya Breakdown of academic impact, for papers by Ola Granström Breakdown of academic impact, for papers by Frank D. Gianfrancesco Breakdown of academic impact, for papers by Dana Enkusson Breakdown of academic impact, for papers by Maila Majak Breakdown of academic impact, for papers by Danielle Adams Breakdown of academic impact, for papers by Rodrigo Muñoz Breakdown of academic impact, for papers by B. Lachaux Breakdown of academic impact, for papers by Fernando Cañas Breakdown of academic impact, for papers by Jacqueline Zummo
Rankless by CCL
2026